Hims & Hers Health Inc. buy Guggenheim
Start price
27.02.24
/
50%
€12.65
Target price
27.02.25
€15.66
Performance (%)
6.92%
Price
02.09.24
€13.53
Summary
This prediction is currently active. With a performance of 6.92%, the BUY prediction by Guggenheim for Hims & Hers Health Inc. is trending in the right direction. This prediction currently runs until 27.02.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Hims & Hers Health Inc. | -5.913% | -5.913% |
iShares Core DAX® | 1.663% | 6.945% |
iShares Nasdaq 100 | 1.261% | 4.883% |
iShares Nikkei 225® | 0.654% | 10.007% |
iShares S&P 500 | 1.403% | 4.350% |
Comments by Guggenheim for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Guggenheim from $15.00 to $17.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Stopped prediction by Guggenheim for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€11.00
28.02.23
28.02.23
€14.12
28.02.24
28.02.24
12.73%
29.02.24
29.02.24